Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data (R24 Clinical Trial Not Allowed)

Active
Yes
Status
Posted
Published Date
March 14th, 2024
Close Date
July 8th, 2024
Award Ceiling
$350,000.00
Opportunity No.
RFA-AT-24-007

Agency

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The National Institutes of Health (NIH) is offering a limited competition grant opportunity for a Research Resource for Natural Product Nuclear Magnetic Resonance (NMR) Data. This grant aims to support the sustainability, scaling, and wider community inclusiveness of an established NMR research resource. The resource consists of raw and meta-data from natural products, ranging from crude extracts to purified substances, and has the capacity to upload, download, store, search, and analyze raw NMR data. The purpose of this grant is to promote research in the field of natural products and advance the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. The grant does not require cost sharing or matching and is open to various eligible applicants. The closing date for applications is July 8, 2024. For more information and to apply, please visit the following link: http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-24-007.html.

Description

The National Center for Complementary and Integrative Health (NCCIH) with the Office of Dietary Supplements (ODS) solicit limited applications for continuation of an established nuclear magnetic resonance (NMR) research resource consisting of raw and meta-data from natural products ranging from crude extracts to purified substances; with the capacity to upload, download, store, search and analyze raw NMR data. The purpose of this limited competition is to promote sustainability, scaling and wider community inclusiveness of the established NMR research resource. This notice of funding opportunity (NOFO) is part of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include the Botanical Dietary Supplements Translational Research Teams (RM1) and Leveraging Big Data to Understand Natural Product Impacts on Whole Person Health (R01).

Contact Information

Attachments
0 KB

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)". This grant aims to support investigator-initiated, early phase, clinical trials of natural products, including botanicals, probiotics, and dietary supplements. The trials should have a strong scientific premise and provide valuable information for further clinical testing and development of the natural product. The grant provides up to three years of support for milestone-driven testing of pharmacokinetics, bioavailability, and assessment of the natural product's effect on a specified target measure. If milestones are achieved, additional support may be awarded to replicate the impact of the natural product on target engagement and assess its association with clinical outcomes. The grant does not require cost sharing or matching. The deadline for applications is November 13, 2026. For more information and to apply, visit the NIH grants website at [http://grants.nih.gov/grants/guide/pa-files/PAR-24-124.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-124.html).
Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01 Clinical Trial Not Allowed)". This grant aims to support the development, adaptation, and/or application of computational tools to aggregate and analyze chemical and/or biological data sets related to natural products. The goal is to generate novel testable hypotheses regarding their biological activity and role in the context of whole person health research. Projects must leverage and merge multiple compatible or interoperable sources and/or types of data, with the use of artificial intelligence and machine learning approaches encouraged. This grant is part of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-24-008.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-24-008.html).
Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)". This grant aims to support collaborative and translational research projects focused on chemically complex botanical and other natural products relevant to dietary supplements. The goal is to conduct highly informative clinical trials to measure the effects of these products on quantitative, objective measures of human resilience. The grant seeks to foster dynamic and synergistic interactions among experts from various disciplines to ensure rigor in all aspects of the research. The projects will be carried out by multi-PD/PI teams working on integrated specific aims. The research outcomes will include optimal parameters for a future proposed clinical efficacy trial, as well as the development and validation of critical knowledge and methods for interpreting such a trial. The grant also emphasizes the importance of enhancing workforce and institutional capacity to conduct rigorous, transdisciplinary research on chemically complex natural products. The ultimate aim is to provide a strong foundation for a future highly informative clinical efficacy trial on the effects of resilience using a chemically complex natural product. This grant opportunity is part of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of the program include RFA-AT-24-008, which focuses on leveraging data at scale to understand natural product impacts on whole person health (R01), and RFA-AT-24-007, which is a limited competition for a research resource on natural product nuclear magnetic resonance data (R24). The deadline for applications is July 8, 2024. The maximum award ceiling is $1,500,000. Eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, non-domestic (non-U.S.) entities (foreign organizations), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. territories or possessions. For more information and to apply, please visit the following link: [Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)](http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-24-014.html). If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)". This grant aims to support investigator-initiated mid-phase clinical trials of natural products, including botanicals, dietary supplements, and probiotics. The purpose of these trials is to further test natural products that have a strong scientific basis and show potential for clinical use. Applicants are required to provide preliminary data demonstrating the bioavailability and measurable impact of the natural product on target engagement. The trials proposed under this grant should focus on determining the optimal dose or formulation of the natural product for future efficacy trials, or identifying patient phenotypes that respond to the natural product. The trials should be hypothesis-based, milestone-driven, and aligned with the research priorities and mission of the National Center for Complementary and Integrative Health (NCCIH). It is important to note that this grant does not support single-site or multi-site efficacy or effectiveness trials, nor trials for the treatment or prevention of cancer using natural products. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and Historically Black Colleges and Universities (HBCUs), among others. The deadline for submitting applications is November 13, 2026. For more information and to apply, interested parties can visit the following website: [NCCIH Natural Product Mid Phase Clinical Trial Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-24-115.html). For any inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.